TiGenix's IPO

TiGenix raised a round of funding on March 22, 2007. Investors include Public.

TiGenix (NYSE Euronext: TIG) is a European cell therapy company with an advanced clinical stage pipeline of adult stem cell programs, and a commercialized product.…

Articles about TiGenix's IPO: